Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), a leading specialist in isotope-related components for nuclear medicine and radiation therapy, announced its participation in the 44th Annual J.P. Morgan Healthcare Conference. The event will take place on Wednesday, 14 January 2026, at the Westin St. Francis in San Francisco, CA, USA. Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE, will present the company at 17:15 PST. The presentation will be available as an audio livestream on the company's website at https://www.ezag.com/investors/presentations/, and the recording will remain accessible for approximately 30 days.
This participation underscores Eckert & Ziegler's growing prominence in the radiopharmaceutical industry, which is experiencing rapid advancements driven by the increasing use of targeted radionuclide therapies for cancer treatment. The J.P. Morgan Healthcare Conference is one of the largest and most influential industry gatherings, attracting key stakeholders from across the healthcare spectrum. For Eckert & Ziegler, presenting at this conference provides a platform to showcase its comprehensive suite of services—from early development to contract manufacturing and distribution—to a global audience of investors, partners, and peers.
The company's focus on isotope-related components positions it at the heart of nuclear medicine, a field that has seen significant innovation with new radiopharmaceuticals gaining regulatory approvals. Eckert & Ziegler's involvement in the conference signals its strategic intent to capitalize on these trends, potentially expanding its market share and forging new collaborations. The live audio stream and subsequent recording ensure that stakeholders who cannot attend in person can still access the company's strategic vision.
With over 1,000 employees, Eckert & Ziegler is a key player in the TecDAX index, reflecting its technological leadership and financial stability. The company's contribution to saving lives through nuclear medicine is a core part of its identity, and its participation in this high-profile conference is likely to attract increased attention from the investment community.
For additional information, investors and media can contact Karolin Riehle, Investor Relations, at the company's Berlin headquarters. The original press release is available at https://www.newmediawire.com.
